Target intelligence / Profile preview

DnaJ heat shock protein family member C21 (DNAJC21)

Target
DNAJC21
Molecular classification
Chaperone (Heat shock protein 40 family), Co-chaperone for HSP70
01

Overview

DnaJ heat shock protein family member C21 (DNAJC21) is a ubiquitously expressed nuclear and cytoplasmic co-chaperone involved mainly in rRNA biogenesis and the maturation of the 60S ribosomal subunit. DNAJC21 binds precursor 45S rRNA, associates with key cofactors such as PA2G4, ZNF622, and HSPA8, and is essential for proper nucleo-cytoplasmic transport and final maturation of ribosomal subunits. Germline mutations cause a cancer-prone bone marrow failure syndrome, manifesting as hematopoietic defects, cytopenia, impaired cell growth, and increased disease risk, particularly acute myeloid leukemia. Deficits in DNAJC21 lead to abnormal ribosome profiles, cell death, and increased sensitivity to ribosome synthesis inhibitors, highlighting its fundamental role in cellular protein homeostasis and human disease[1][2][3].

Other names
DnaJ homolog subfamily C member 21DNAJC21DNAJA5GS3JJJ1BMFS3Protein GS3DnaJ (Hsp40) homolog subfamily C member 21DnaJ homology subfamily A member 5JJJ1 DnaJ domain protein homologDnaJ homolog subfamily A member 5[3]
02

Mechanism of action

Drugs that affect ribosomal RNA synthesis (such as Actinomycin D) can have increased cytotoxicity in DNAJC21-deficient cells due to impaired rRNA biogenesis[1]

03

Biological functions

Ribosomal RNA biogenesis60S ribosomal subunit maturationProtein synthesisCell proliferationHematopoietic differentiation[1][2][3]
04

Disease associations

Bone marrow failure syndrome (BMF)Shwachman-Diamond-like syndromeCancer predisposition (especially myeloid malignancies)[1][2][3]
05

Safety considerations

Increased risk of bone marrow failurePotential development of acute myeloid leukemia and other hematological malignancies in mutation carriersEnhanced sensitivity to RNA polymerase inhibitors (e.g., Actinomycin D) due to impaired rRNA synthesis[1][2]
06

Interacting drugs

Actinomycin D (cell sensitivity noted in deficient cells, but not a targeted direct inhibitor)[1]
07

Biomarkers

Mutations in DNAJC21 (biallelic) for detection of Bone Marrow Failure Syndrome 3Decreased rRNA levelsAberrant polysome/ribosome profiles[1][2][3]

Beyond the preview

Go deeper on DnaJ heat shock protein family member C21 (DNAJC21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DnaJ heat shock protein family member C21 (DNAJC21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call